Donna F. Zarcone - Apr 27, 2022 Form 4 Insider Report for Cigna Corp (CI)

Role
Director
Signature
By: Jill M. Stadelman, attorney-in-fact
Stock symbol
CI
Transactions as of
Apr 27, 2022
Transactions value $
$0
Form type
4
Date filed
4/29/2022, 06:11 PM
Previous filing
Mar 14, 2022
Next filing
Jun 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Award $0 +757 +2.82% $0.00 27.6K Apr 27, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 39 and 101 of Cigna's proxy statement filed with the SEC on March 18, 2022.

Remarks:

Exhibit List: EX-24 Power of Attorney poazarcone.txt